User:Mr. Ibrahem/Basiliximab

Basiliximab, sold under the brand name Simulect, is a medication used to prevent rejection following a kidney transplant. It is used together with ciclosporin and corticosteroids. It is given by injection into a vein.

Common side effects include constipation, nausea, abdominal pain, heart burn, high potassium, low potassium, headache, swelling, fever, shortness of breath, and trouble sleeping. Other side effects may include infections and anaphylaxis. Use in pregnancy is not recommended. It is a monoclonal antibody that attaches to CD25 on T cells and thus blocks interleukin-2.

Basiliximab was approved for medical use in the United States and Europe in 1998. In the United Kingdom a typical dose costs about £840 as of 2021. In the United States this amount costs about 4,100 USD.